# Plagl1 regulates the retinal progenitor cell to Müller glial cell transition

**Authors:** Yacine Touahri, Alissa Pak, Luke Ajay David, Joseph Hanna, Hedy Liu, Yucheng Xiao, Lauren Belfiore, Yaroslav Ilnytskyy, Edwin van Oosten, Nobuhiko Tachibana, Lata Adnani, Jiayi Zhao, Mary Hoffman, Rajiv Dixit, Dawn Zinyk, Cynthia J. Guidos, Volker Enzmann, Pengpeng Bi, Isabelle Aubert, Laurent Journot, Igor Kovalchuk, Yves Sauvé, Jeff Biernaskie, Chao Wang, Satoshi Okawa, Antonio del Sol, Carol Schuurmans, Fengwei Yu, Fengwei Yu, Fengwei Yu, Fengwei Yu

PMC · DOI: 10.1371/journal.pgen.1012020 · PLOS Genetics · 2026-03-18

## TL;DR

This study shows that the Plagl1 gene is crucial for the transition of retinal progenitor cells into Müller glia, ensuring proper retinal development and function.

## Contribution

The study identifies Plagl1 as a novel regulator of the RPC-to-Müller glia transition through its role in chromatin accessibility and gene expression.

## Key findings

- Plagl1 loss disrupts chromatin and transcriptional programs in Sox9+ cells, leading to structural defects in Müller glia.
- Conditional deletion of Plagl1 in postnatal Müller glia disrupts cell positioning but not cell cycle exit.
- Plagl1 regulates the transition from retinal progenitor cells to Müller glia by controlling gene expression and chromatin accessibility.

## Abstract

Müller glia arise from late-stage retinal progenitor cells (RPCs) as a distinct lineage that diverges from neurogenic trajectories. Here, we identify the maternally imprinted gene Plagl1 as a key transcriptional regulator of gliogenesis in the murine retina. Plagl1 is expressed during the RPC-to-glia transition and is dynamically regulated in Müller glia following injury. To define its developmental role, we analyzed Plagl1⁺/⁻pat null mutant retinas at postnatal day 7 (P7), when central retinal gliogenesis is complete. In the absence of Plagl1, Sox9 ⁺ glial/precursor cells were displaced and proliferated ectopically, with structural dysmorphologies, reactive gliosis, and impaired visual processing persisting into later postnatal stages. Bulk RNA-seq and ATAC-seq revealed widespread reductions in chromatin accessibility and transcriptional dysregulation affecting epigenetic modifiers, translational machinery, fate-specifying transcription factors, cell cycle regulators, and signaling pathways. Single-cell pseudobulk analysis showed that Plagl1 loss disrupts chromatin, transcriptional, and translational programs specifically within Sox9 ⁺ cells, encompassing Müller glia and precursor populations, pinpointing these cells as the source of defects in Plagl1⁺/⁻pat retinas. Notch signaling was elevated in Plagl1-deficient glia, and genetic activation at P14 displaced Sox9 ⁺ glial cells, without inducing proliferation. Similarly, conditional deletion of Plagl1 in postnatal Müller glia at P14 disrupted positioning and not cell cycle exit, confirming a cell-autonomous requirement for Müller glia positioning that is independent of proliferation control. Since these conditional manipulations could only be performed at P14 at the earliest, they reveal Plagl1’s later functions in postmitotic glia and complement, rather than mirror, the earlier P7 mixed RPC/glial null phenotype. Together these findings establish Plagl1 as a critical regulator of the late-stage RPC to Müller glia transition, acting through coordinated control of chromatin accessibility and gene expression programs to ensure timely cell cycle exit. This function aligns with Plagl1’s broader tumor suppressor role in stabilizing postmitotic, differentiated cell states across tissues.

As the only glial cells in the retina, Müller glia play an essential role in maintaining tissue homeostasis and supporting retinal integrity and function. During development, Müller glia are derived from multipotent RPCs, which also give rise to the six types of retinal neurons, all of which differentiate in a defined temporal order. Müller glia are among the last retinal cells to differentiate, transitioning from cycling RPCs into post-mitotic glial cells. Here, we show that the RPC-to-Müller glial cell transition is orchestrated by the maternally imprinted gene Plagl1. Plagl1 encodes a transcription factor that is initially expressed in RPCs and later persists in retinal Müller glia. In the absence of Plagl1, Müller glia initiate glial-specific marker expression but fail to form a mature monolayer and continue to proliferate ectopically. Mechanistically, loss of Plagl1 compacts open chromatin, induces widespread changes in gene expression, and elevates several signaling pathways including Notch, which, when activated, disrupts the Müller glial monolayer. Thus, Plagl1 guides the RPC-to-Müller glial cell transition, providing new insights into this unique developmental process.

## Linked entities

- **Genes:** PLAGL1 (PLAG1 like zinc finger 1) [NCBI Gene 5325], SOX9 (SRY-box transcription factor 9) [NCBI Gene 6662]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Hes5 (hes family bHLH transcription factor 5) [NCBI Gene 15208] {aka bHLHb38}, Cdk11b (cyclin dependent kinase 11B) [NCBI Gene 12537] {aka CDK11-p110, CDK11-p46, CDK11-p58, Cdc11b, Cdc2l1, Cdc2l2}, Smarcd1 (SWI/SNF related BAF chromatin remodeling complex subunit D1) [NCBI Gene 83797] {aka Baf60a, D15Kz1}, Vsx2 (visual system homeobox 2) [NCBI Gene 171360] {aka Chx10}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, Plagl1 (PLAG1 like zinc finger 1) [NCBI Gene 25157] {aka Lot1, Zac1}, Calb2 (calbindin 2) [NCBI Gene 117059], Eif2s3x (eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked) [NCBI Gene 26905] {aka Eif-2gx, eIF-2-gamma X}, Gt(ROSA)26Sor (gene trap ROSA 26, Philippe Soriano) [NCBI Gene 14910] {aka Gtrgeo26, Gtrosa26, R26, ROSA26, Thumpd3as1}, Ccne2 (cyclin E2) [NCBI Gene 12448], Mars2 (methionine-tRNA synthetase 2 (mitochondrial)) [NCBI Gene 212679] {aka C730026E21Rik, MetRS}, Lhx2 (LIM homeobox protein 2) [NCBI Gene 16870] {aka LH2A, Lh-2, Lim2, ap, apterous}, Plagl1 (pleiomorphic adenoma gene-like 1) [NCBI Gene 22634] {aka 2610311E24Rik, Lot1, Zac1}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}, Casz1 (castor zinc finger 1) [NCBI Gene 69743] {aka 2410019P08Rik, Cst, D4Ertd432e}, Atn1 (atrophin 1) [NCBI Gene 13498] {aka Atr1, Drpla, atrophin-1}, Hes6 (hairy and enhancer of split 6) [NCBI Gene 55927] {aka bHLHb41}, Pax6 (paired box 6) [NCBI Gene 25509], Tjp1 (tight junction protein 1) [NCBI Gene 21872] {aka ZO1}, Calb1 (calbindin 1) [NCBI Gene 12307] {aka Brain-2, CB, Calb, Calb-1}, Ms6hm (minisatellite 6 hypermutable) [NCBI Gene 17653] {aka PC-1}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, Igf2 (insulin-like growth factor 2) [NCBI Gene 16002] {aka Igf-2, Igf-II, M6pr, Mpr, Peg2}, Arr3 (arrestin 3) [NCBI Gene 171107], Rps7 (ribosomal protein S7) [NCBI Gene 20115] {aka Mtu, Rps7A, S7}, Chd4 (chromodomain helicase DNA binding protein 4) [NCBI Gene 107932] {aka 9530019N15Rik, D6Ertd380e, Mi-2beta, mKIAA4075}, Cdkn1b (cyclin dependent kinase inhibitor 1B) [NCBI Gene 12576] {aka Kip1, p27, p27Kip1}, Notch2 (notch 2) [NCBI Gene 18129] {aka N2}, Arr3 (arrestin 3, retinal) [NCBI Gene 170735] {aka Arr4, Car, Carfl, Carr}, Pou2f1 (POU domain, class 2, transcription factor 1) [NCBI Gene 18986] {aka 2810482H01Rik, NF-A1, Oct-1, Oct1, Otf-1, Otf1}, Ccng1 (cyclin G1) [NCBI Gene 12450], Rho (rhodopsin) [NCBI Gene 212541] {aka Noerg1, Opn2, Ops, RP4}, Sox9 (SRY (sex determining region Y)-box 9) [NCBI Gene 20682] {aka 2010306G03Rik, mKIAA4243, mSox9}, Crx (cone-rod homeobox) [NCBI Gene 12951] {aka Crx1}, Rps28 (ribosomal protein S28) [NCBI Gene 54127], Vsx1 (visual system homeobox 1) [NCBI Gene 114889] {aka CHX10-like}, Id1 (inhibitor of DNA binding 1, HLH protein) [NCBI Gene 15901] {aka D2Wsu140e, Idb1, bHLHb24}, NFIC (nuclear factor I C) [NCBI Gene 4782] {aka CTF, CTF5, NF-I, NF-I/C, NF1-C, NFI}, Pou2f2 (POU domain, class 2, transcription factor 2) [NCBI Gene 18987] {aka Oct-2, Oct2a, Oct2b, Oct2c, Oct2d, Otf-2}, Rps27 (ribosomal protein S27) [NCBI Gene 57294] {aka 3200001M24Rik}, Hmgn2 (high mobility group nucleosomal binding domain 2) [NCBI Gene 15331] {aka HMG-17, Hmg17}, Tcf4 (transcription factor 4) [NCBI Gene 21413] {aka 5730422P05Rik, ASP-I2, E2-2, E2.2, ITF-2, ITF-2b}, DLL1 (delta like canonical Notch ligand 1) [NCBI Gene 28514] {aka DELTA1, DL1, Delta, NEDBAS}, Ddx3x (DEAD box helicase 3, X-linked) [NCBI Gene 13205] {aka D1Pas1-rs2, Ddx3, Fin14}, Nfix (nuclear factor I/X) [NCBI Gene 18032] {aka CTF, NF-I/X, NF1-X, NFI-X}, Hes1 (hes family bHLH transcription factor 1) [NCBI Gene 15205] {aka Hry, bHLHb39}, Kdm6a (lysine (K)-specific demethylase 6A) [NCBI Gene 22289] {aka Utx}, Crb1 (crumbs family member 1, photoreceptor morphogenesis associated) [NCBI Gene 170788] {aka 7530426H14Rik, A930008G09Rik, CRB1-A, CRB1-A2, CRB1-B, CRB1-C}, Rtca (RNA 3'-terminal phosphate cyclase) [NCBI Gene 66368] {aka 2310009A18Rik, RPC, Rtcd1}, Ikzf4 (IKAROS family zinc finger 4) [NCBI Gene 22781] {aka A630026H08Rik, Eos, Zfpn1a4, Znfn1a4}, Cdkn1a (cyclin dependent kinase inhibitor 1A) [NCBI Gene 12575] {aka CAP20, CDKI, CIP1, Cdkn1, P21, SDI1}, Itprid2 (ITPR interacting domain containing 2) [NCBI Gene 70599] {aka 5730488C15Rik, CS-1, CS1, KRAP, SPAG13, Ssfa2}, PLAGL1 (PLAG1 like zinc finger 1) [NCBI Gene 5325] {aka LOT1, ZAC, ZAC1}, Cdkn2d (cyclin dependent kinase inhibitor 2D) [NCBI Gene 12581] {aka INK4d, p19, p19INK4d}, Prkcg (protein kinase C, gamma) [NCBI Gene 24681] {aka PKC, PKCI, Prkc, Prkcc, RATPKCI}, Rps21 (ribosomal protein S21) [NCBI Gene 66481] {aka 1810049N11Rik, 2410030A14Rik}, Rpl26 (ribosomal protein L26) [NCBI Gene 19941] {aka SIG-20}, Neurog2 (neurogenin 2) [NCBI Gene 11924] {aka Atoh4, Math4A, bHLHa8, ngn-2, ngn2}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}
- **Diseases:** retinal damage (MESH:D012164), MG (MESH:D009157), Gliosis (MESH:D005911), cancers (MESH:D009369), impaired visual function (MESH:D014786), hypertrophy (MESH:D006984), intrauterine grown restriction (MESH:D005317), ectopia (MESH:C563268), photoreceptor degeneration (MESH:D009410), inflammatory (MESH:D007249), defects (MESH:D000013), RPCs (MESH:D012173), Muller (MESH:C537370), SPECIFIC COMMENTS (MESH:D000080888), colorectal cancers (MESH:D015179), MNU (MESH:C536108), breast, ovarian, prostate, pituitary, gastric, non-Hodgkin's lymphoma (MESH:D011472)
- **Chemicals:** Pen (MESH:C058388), isoflurane (MESH:D007530), Alexa-568 (MESH:C000607448), DMSO (MESH:D004121), NaF (MESH:D012969), sucrose (MESH:D013395), BrdU (MESH:D001973), CO2 (MESH:D002245), Tamoxifen (MESH:D013629), 4-hydroxy-tamoxifen (MESH:C016601), Aqua (MESH:D014867), 4-OHT (MESH:C032278), puromycin (MESH:D011691), 00207R1 (-), MNU (MESH:D008770), Ethanol (MESH:D000431), Triton X-100 (MESH:D017830), Mydriacyl (MESH:D014331), L-Glutamine (MESH:D005973), PFA (MESH:C003043), SDS (MESH:D012967), DAPI (MESH:C007293), K+ (MESH:D011188), Trizol (MESH:C411644), biotin (MESH:D001710), N-methyl-D-aspartate (MESH:D016202), peanut oil (MESH:D000074241), Alexa-647 (MESH:C569686), HEPES (MESH:D006531)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090], Rodentia (rodent, order) [taxon 9989], Danio rerio (leopard danio, species) [taxon 7955], Gallus gallus (bantam, species) [taxon 9031], Xenopus laevis (African clawed frog, species) [taxon 8355], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A 30G, W539L, I site located 601 bp
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), RPE — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_4388)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13016477/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13016477/full.md

## References

114 references — full list in the complete paper: https://tomesphere.com/paper/PMC13016477/full.md

---
Source: https://tomesphere.com/paper/PMC13016477